These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36472509)

  • 1. Effectiveness of Five Antibiotic Regimens for the Treatment of Intra-Abdominal Infection in Bogotá.
    López GAM; Rodríguez LFC; Fandiño LCS; Lasso AD; Granados JPA; Salazar YID; Pereira KA; Velásquez JP; Luna JAC; Trujillo CHS
    Surg Infect (Larchmt); 2022 Dec; 23(10):933-939. PubMed ID: 36472509
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibiotic Resistance in Community-Acquired Intra-Abdominal Infections: Diabetes Mellitus as a Risk Factor.
    Núñez SA; Lacal V; Núñez J; Serruto G; Zárate MS; Verón MT
    Surg Infect (Larchmt); 2020 Feb; 21(1):62-68. PubMed ID: 31441705
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of ceftolozane/tazobactam plus metronidazole compared with piperacillin/tazobactam as empiric therapy for the treatment of complicated intra-abdominal infections based on the in-vitro surveillance of bacterial isolates in the UK.
    Prabhu V; Foo J; Ahir H; Sarpong E; Merchant S
    J Med Econ; 2017 Aug; 20(8):840-849. PubMed ID: 28532194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-abdominal infections: the role of different classifications on the selection of the best antibiotic treatment.
    Silva-Nunes J; Cardoso T
    BMC Infect Dis; 2019 Nov; 19(1):980. PubMed ID: 31752716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision-making analysis for selection of antibiotic treatment in intra-abdominal infection using preference measurements.
    Sanabria A
    Surg Infect (Larchmt); 2006 Oct; 7(5):453-62. PubMed ID: 17083311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Anti-Enterococcal Therapy for Intra-Abdominal Infection.
    Zhang J; Yu WQ; Chen W; Wei T; Wang CW; Zhang JY; Zhang Y; Liang TB
    Surg Infect (Larchmt); 2021 Mar; 22(2):131-143. PubMed ID: 32471332
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospective, randomized, study of ampicillin-sulbactam versus moxifloxacin monotherapy for the treatment of community-acquired complicated intra-abdominal infections.
    Chen CW; Ming CC; Ma CJ; Shan YS; Yeh YS; Wang JY
    Surg Infect (Larchmt); 2013 Aug; 14(4):389-96. PubMed ID: 23859673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Duration and Empiric Antibiotic Choice of Post-Operative Treatment in Abdominal Sepsis.
    Surat G; Meyer-Sautter P; Rüsch J; Braun-Feldweg J; Germer CT; Lock JF
    Surg Infect (Larchmt); 2022 Jun; 23(5):444-450. PubMed ID: 35532964
    [No Abstract]   [Full Text] [Related]  

  • 9. Time to source control and outcome in community-acquired intra-abdominal infections: The multicentre observational PERICOM study.
    Roger C; Garrigue D; Bouhours G; Dupont H; Bouzat P; Bardon J; Pottecher J; Montravers P; Michelet P; Perbet S; Aymart K; Incagnoli P; Lloret S; Louart B; Harrois A;
    Eur J Anaesthesiol; 2022 Jun; 39(6):540-548. PubMed ID: 35608877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI).
    Kongnakorn T; Eckmann C; Bassetti M; Tichy E; Di Virgilio R; Baillon-Plot N; Charbonneau C
    Antimicrob Resist Infect Control; 2019; 8():204. PubMed ID: 31890160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifaceted intervention to optimize antibiotic use for intra-abdominal infections.
    Popovski Z; Mercuri M; Main C; Sne N; Walsh K; Sung M; Rice T; Mertz D
    J Antimicrob Chemother; 2015 Apr; 70(4):1226-9. PubMed ID: 25505004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics for Patients With a Planned Re-Laparotomy for Intra-Abdominal Infection.
    Hochstetler LJ; Olney WJ; Bishop JM; Warriner ZD; VanHoose JD; Mynatt RP; Ali D; Schadler A; Parli SE
    Surg Infect (Larchmt); 2024 Apr; 25(3):192-198. PubMed ID: 38407831
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of body mass index on treatment of complicated intra-abdominal infections in hospitalized adults: comparison of ertapenem with piperacillin-tazobactam.
    Zakrison TL; Hille DA; Namias N
    Surg Infect (Larchmt); 2012 Feb; 13(1):38-42. PubMed ID: 22217196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic Safety and Effectiveness in Premature Infants With Complicated Intraabdominal Infections.
    Smith MJ; Boutzoukas A; Autmizguine J; Hudak ML; Zinkhan E; Bloom BT; Heresi G; Lavery AP; Courtney SE; Sokol GM; Cotten CM; Bliss JM; Mendley S; Bendel C; Dammann CEL; Weitkamp JH; Saxonhouse MA; Mundakel GT; Debski J; Sharma G; Erinjeri J; Gao J; Benjamin DK; Hornik CP; Smith PB; Cohen-Wolkowiez M;
    Pediatr Infect Dis J; 2021 Jun; 40(6):550-555. PubMed ID: 33902072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS).
    Thomson KM; Dyer C; Liu F; Sands K; Portal E; Carvalho MJ; Barrell M; Boostrom I; Dunachie S; Farzana R; Ferreira A; Frayne F; Hassan B; Jones E; Jones L; Mathias J; Milton R; Rees J; Chan GJ; Bekele D; Mahlet A; Basu S; Nandy RK; Saha B; Iregbu K; Modibbo F; Uwaezuoke S; Zahra R; Shirazi H; Syed NU; Mazarati JB; Rucogoza A; Gaju L; Mehtar S; Bulabula ANH; Whitelaw A; van Hasselt JGC; Walsh TR;
    Lancet Infect Dis; 2021 Dec; 21(12):1677-1688. PubMed ID: 34384533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Evaluation of Antibiotic Usage in Complicated Intra-Abdominal Infection after the STOP IT Trial: Did We STOP IT?
    Posillico SE; Young BT; Ladhani HA; Zosa BM; Claridge JA
    Surg Infect (Larchmt); 2019 Apr; 20(3):184-191. PubMed ID: 30676237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged Therapy Is Not Associated with Delayed Identification of Recurrent Intra-Abdominal Infection.
    Dulek A; O'Dell JC; Guidry CA
    Surg Infect (Larchmt); 2022 Nov; 23(9):796-800. PubMed ID: 36251958
    [No Abstract]   [Full Text] [Related]  

  • 18. Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India.
    Chandra A; Dhar P; Dharap S; Goel A; Gupta R; Hardikar JV; Kapoor VK; Mathur AK; Modi P; Narwaria M; Ramesh MK; Ramesh H; Sastry RA; Shah S; Virk S; Sudheer OV; Sreevathsa MR; Varshney S; Kochhar P; Somasundaram S; Desai C; Schou M
    Surg Infect (Larchmt); 2008 Jun; 9(3):367-76. PubMed ID: 18570578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of excessive duration of antibiotic therapy for intra-abdominal infection with subsequent extra-abdominal infection and death: a study of 2,552 consecutive infections.
    Riccio LM; Popovsky KA; Hranjec T; Politano AD; Rosenberger LH; Tura KC; Sawyer RG
    Surg Infect (Larchmt); 2014 Aug; 15(4):417-24. PubMed ID: 24824591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic and Duration of Perioperative Prophylaxis Predicts Surgical Site Infection in Head and Neck Surgery.
    Langerman A; Thisted R; Hohmann S; Howell M
    Otolaryngol Head Neck Surg; 2016 Jun; 154(6):1054-63. PubMed ID: 26932957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.